CIP2A and cancer: These results show that many small molecule inhibitors of proteases (MG-132, MLN- 2238) and CIP2A interacting proteins such as mTOR inhibitors (Torin-2) were identified, which have been studied for their possible use for cancer treatment, yielding positive results in vivo56.